Inflammation, Uveitis
Conditions
Brief summary
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants
Detailed description
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants on corneal endothelial cell density.
Interventions
PROCEDUREFluocinolone Acetonide 0.59 mg
At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.
PROCEDUREFluocinolone Acetonide 2.1 mg
At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.
Sponsors
Bausch & Lomb Incorporated
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Had the FA intravitreal implant (0.59 or 2.1 mg) in only one eye for at least one(1) year * Able and willing to follow instructions * Able and willing to provide informed consent
Exclusion criteria
* Is monocular * Has current or relevant medical history that would interfere with their participation in this study, based on the judgment of the Investigator * Had bilateral FA intravitreal implants * Has a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Corneal Endothelial Cell Density | 1 Visit | Bilateral specular microscopy will be performed and endothelial cell density will be recorded. |
Countries
United States
Outcome results
None listed